Nephro Di Therapeutics, Inc. announced it raised $1.6 Million in an initial filing from an offering of $1.6 Million
Nephro Di Therapeutics, Inc. announced it raised $1.6 Million in an initial filing from an offering of $1.6 Million
02/23/21, 5:57 PM
Location
seattleMoney raised
$1.6 million
Industry
healthcare
Round Type
seed
Company Info
Location
2200 32nd ave w
seattle, washington, united states
Additional Info
NephroDI Therapeutics is a pre-clinical development stage biopharmaceutical company that focuses on concentration disorders of the kidney. The initial clinical indication for its orally administered lead small molecule is for Nephrogenic Diabetes Insipidus in children, a pediatric orphan indication.